Frontotemporal Dementia, Behavioral Variant Clinical Trials
2 recruiting trials for Frontotemporal Dementia, Behavioral Variant. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Frontotemporal Dementia, Behavioral Variant clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Institut National de la Santé Et de la Recherche Médicale, France (1), Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Remote collection of passive and active data for 28 consecutive days (other, 1 trial), followed by DISBAND protocol.
Track Frontotemporal Dementia, Behavioral Variant trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
ECOCAPTURE for the Assessment of Apathy Under Real-life Conditions
ECOCAPTURE@HOME is a study which is currently being developed with the objective to capture the behavioral signature of apathy in everyday life context through remote monitoring...
A Study of the Behavioral Variant of Frontotemporal Dementia and Bipolar Disorder: a Neuroimaging and Epigenetics...
The aim of this study is to investigate the selective epigenetic modifications and their effect on brain's morphology and functionality in the frontotemporal dementia behavioral...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Frontotemporal Dementia, Behavioral Variant, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Frontotemporal Dementia, Behavioral Variant, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Frontotemporal Dementia, Behavioral Variant, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.